Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Xuan Qin

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Sarcoma|June 16, 2015
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue SarcomaMark A Dickson, David R D'Adamo, Mary L Keohan, et al.
Cancer Discovery|September 1, 2016
Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade MyxofibrosarcomaTomoyo Okada, Ann Y Lee, Li-Xuan Qin, et al.
Plos One|July 14, 2012
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkersJordan M Winter, Laura H Tang, David S Klimstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical OutcomeEvan Rosenbaum, Kenneth Seier, Chaitanya Bandlamudi, et al.
The Oncologist|August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath TumorsDavid R D'Adamo, Mark A Dickson, Mary L Keohan, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomasMrinal Gounder, Ved Desai, Deborah Kuk, et al.
Transplantation and Cellular Therapy|February 24, 2025
Infections in Patients with Solid Tumors Undergoing Adoptive Cellular TherapyViswatej Avutu, Jumanah N Algazaq, Kenneth Seier, et al.
Cancer Research Communications|October 3, 2023
Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced SarcomasEvan Rosenbaum, Kenneth Seier, Martina Bradic, et al.
JCO Precision Oncology|December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.
Investigational New Drugs|August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumorCiara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Sarcoma|June 16, 2015
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue SarcomaMark A Dickson, David R D'Adamo, Mary L Keohan, et al.
Cancer Discovery|September 1, 2016
Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade MyxofibrosarcomaTomoyo Okada, Ann Y Lee, Li-Xuan Qin, et al.
Plos One|July 14, 2012
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkersJordan M Winter, Laura H Tang, David S Klimstra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical OutcomeEvan Rosenbaum, Kenneth Seier, Chaitanya Bandlamudi, et al.
The Oncologist|August 22, 2018
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath TumorsDavid R D'Adamo, Mark A Dickson, Mary L Keohan, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2015
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomasMrinal Gounder, Ved Desai, Deborah Kuk, et al.
Transplantation and Cellular Therapy|February 24, 2025
Infections in Patients with Solid Tumors Undergoing Adoptive Cellular TherapyViswatej Avutu, Jumanah N Algazaq, Kenneth Seier, et al.
Cancer Research Communications|October 3, 2023
Immune-related Adverse Events after Immune Checkpoint Blockade-based Therapy Are Associated with Improved Survival in Advanced SarcomasEvan Rosenbaum, Kenneth Seier, Martina Bradic, et al.
JCO Precision Oncology|December 7, 2020
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway GenesEvan Rosenbaum, Philip Jonsson, Kenneth Seier, et al.
Investigational New Drugs|August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumorCiara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
Pageof 14